These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 25035669)

  • 1. Prognostic Significance of the Lymphoblastic Leukemia-Derived Sequence 1 (LYL1) GeneExpression in Egyptian Patients with AcuteMyeloid Leukemia.
    El-Menshawy N; Shahin D; Ghazi HF
    Turk J Haematol; 2014 Jun; 31(2):128-35. PubMed ID: 25035669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of transcription factor LYL1 in leukemia and its possible role in leukemogenesis].
    Meng YS; Zhang YX; Ai GW; Meng XQ; Liu W; Wei R; Jiang W
    Zhonghua Xue Ye Xue Za Zhi; 2008 Nov; 29(11):749-52. PubMed ID: 19176012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogenic potential of the transcription factor LYL1 in acute myeloblastic leukemia.
    Meng YS; Khoury H; Dick JE; Minden MD
    Leukemia; 2005 Nov; 19(11):1941-7. PubMed ID: 16094422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ecotropic virus integration site-1 gene preferentially expressed in post-myelodysplasia acute myeloid leukemia: possible association with GATA-1, GATA-2, and stem cell leukemia gene expression.
    Ohyashiki JH; Ohyashiki K; Shimamoto T; Kawakubo K; Fujimura T; Nakazawa S; Toyama K
    Blood; 1995 Jun; 85(12):3713-8. PubMed ID: 7780155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The NUP98-HOXD13 fusion oncogene induces thymocyte self-renewal via Lmo2/Lyl1.
    Shields BJ; Slape CI; Vo N; Jackson JT; Pliego-Zamora A; Ranasinghe H; Shi W; Curtis DJ; McCormack MP
    Leukemia; 2019 Aug; 33(8):1868-1880. PubMed ID: 30700838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The expression pattern of erythrocyte/megakaryocyte-related transcription factors GATA-1 and the stem cell leukemia gene correlates with hematopoietic differentiation and is associated with outcome of acute myeloid leukemia.
    Shimamoto T; Ohyashiki K; Ohyashiki JH; Kawakubo K; Fujimura T; Iwama H; Nakazawa S; Toyama K
    Blood; 1995 Oct; 86(8):3173-80. PubMed ID: 7579412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a pediatric T-cell acute lymphoblastic leukemia patient with simultaneous LYL1 and LMO2 rearrangements.
    Homminga I; Vuerhard MJ; Langerak AW; Buijs-Gladdines J; Pieters R; Meijerink JP
    Haematologica; 2012 Feb; 97(2):258-61. PubMed ID: 22058201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Abnormal expression of transcription factors LYL1 and LMO2 and interaction between them in myeloid leukemia].
    Meng YS; Wei R; Ai GW; Meng XQ; Zhang YX
    Zhonghua Yi Xue Za Zhi; 2009 Apr; 89(13):890-3. PubMed ID: 19671288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Super-enhancer profiling identifies novel critical and targetable cancer survival gene LYL1 in pediatric acute myeloid leukemia.
    Fang F; Lu J; Sang X; Tao YF; Wang JW; Zhang ZM; Zhang YP; Li XL; Xie Y; Wu SY; Chu XR; Li G; Wu D; Chen YL; Yu JJ; Jia SQ; Feng CX; Tian YY; Li ZH; Ling J; Hu SY; Pan J
    J Exp Clin Cancer Res; 2022 Jul; 41(1):225. PubMed ID: 35842703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Requirement for Lyl1 in a model of Lmo2-driven early T-cell precursor ALL.
    McCormack MP; Shields BJ; Jackson JT; Nasa C; Shi W; Slater NJ; Tremblay CS; Rabbitts TH; Curtis DJ
    Blood; 2013 Sep; 122(12):2093-103. PubMed ID: 23926305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical importance of P-glycoprotein-related resistance in leukemia and myelodysplastic syndromes--first experience with their reversal.
    Nüssler V; Pelka-Fleischer R; Zwierzina H; Nerl C; Beckert B; Gullis E; Gieseler F; Bock S; Bartl R; Petrides PE
    Ann Hematol; 1994; 69 Suppl 1():S25-9. PubMed ID: 7914749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Twice-daily fludarabine and cytarabine combination with or without gentuzumab ozogamicin is effective in patients with relapsed/refractory acute myeloid leukemia, high-risk myelodysplastic syndrome, and blast- phase chronic myeloid leukemia.
    Jabbour E; Garcia-Manero G; Cortes J; Ravandi F; Plunkett W; Gandhi V; Faderl S; O'Brien S; Borthakur G; Kadia T; Burger J; Konopleva M; Brandt M; Huang X; Kantarjian H
    Clin Lymphoma Myeloma Leuk; 2012 Aug; 12(4):244-51. PubMed ID: 22534616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute lymphoid leukemias following either a previous chronic myelogenous leukemia or myelodysplastic syndrome: phenotypic and genomic differences.
    Hernández JM; Sánchez I; González M; Orfao A; González-Sarmiento R; San Miguel JF
    Am J Hematol; 1993 Aug; 43(4):256-8. PubMed ID: 8396849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Helix-loop-helix proteins LYL1 and E2a form heterodimeric complexes with distinctive DNA-binding properties in hematolymphoid cells.
    Miyamoto A; Cui X; Naumovski L; Cleary ML
    Mol Cell Biol; 1996 May; 16(5):2394-401. PubMed ID: 8628307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High incidence of biallelic point mutations in the Runt domain of the AML1/PEBP2 alpha B gene in Mo acute myeloid leukemia and in myeloid malignancies with acquired trisomy 21.
    Preudhomme C; Warot-Loze D; Roumier C; Grardel-Duflos N; Garand R; Lai JL; Dastugue N; Macintyre E; Denis C; Bauters F; Kerckaert JP; Cosson A; Fenaux P
    Blood; 2000 Oct; 96(8):2862-9. PubMed ID: 11023523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple mechanisms induce ectopic expression of LYL1 in subsets of T-ALL cell lines.
    Nagel S; Venturini L; Meyer C; Kaufmann M; Scherr M; Drexler HG; MacLeod RA
    Leuk Res; 2010 Apr; 34(4):521-8. PubMed ID: 19608273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of a transcription factor LYL1 induces T- and B-cell lymphoma in mice.
    Zhong Y; Jiang L; Hiai H; Toyokuni S; Yamada Y
    Oncogene; 2007 Oct; 26(48):6937-47. PubMed ID: 17486074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Differential analysis of BM cell morphology, immunophenotypic, cytogenetic characters and prognosis between myeloblastic and lymphoblastic crisis of CML].
    Liu YL; Wang XN; Liu HS
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):629-33. PubMed ID: 24989266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suspected leukemia oncoproteins CREB1 and LYL1 regulate Op18/STMN1 expression.
    San-Marina S; Han Y; Liu J; Minden MD
    Biochim Biophys Acta; 2012; 1819(11-12):1164-72. PubMed ID: 23000483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.
    Ries C; Loher F; Zang C; Ismair MG; Petrides PE
    Clin Cancer Res; 1999 May; 5(5):1115-24. PubMed ID: 10353746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.